Chrishan Anketell

Chrishan Anketell

Director – Healthcare Analyst
Chrishan Anketell has extensive experience in sell-side equity and fixed income fundamental analysis covering a wide variety of sectors including Medical Devices, Healthcare Services, Biotech, Cleantech and Technology. Mr. Anketell started his career as a Market Research Associate at FTN Midwest Research and has since worked on several highly ranked equity research teams by Institutional Investor and Starmine. Prior to joining Aegis, Chrishan has worked in the equity research capacity at Dahlman Rose & Company, MKM Partners LLC, Northcoast Research Partners and Roth Capital Partners. Throughout his career, Mr. Anketell has been very successful in building solid relationships with industry specialists through intensive channel checks and weekly conference calls. Chrishan was also responsible for interacting with buy-side clients, interfacing with corporate management teams, organizing and attending non-deal roadshows and conferences, tracking industry data, maintaining company specific financial models and authoring a high-quality research product.
Biopharmaceuticals

GLSI Greenwich Lifesciences, Inc.